{"description":"Standard (S)AE definitions. The Intent-to-Treat (ITT) Analysis Set comprised all randomized patients; this represents the population for the calculation of All-Cause Mortality.\n\nThe Safety Analysis Set comprised all patients who received at least 1 dose of study drug; this represents the population for presentation of the Adverse Events data.","eventGroups":[{"deathsNumAffected":24,"deathsNumAtRisk":27,"description":"rAd-IFN (Study Day 1) + celecoxib (Study Days 1 to 14) + gemcitabine (Study Days 14 and 21 \\[i.e., Days 1 and 8 of the first gemcitabine treatment cycle\\], gemcitabine will be administered on a 21-day cycle, unless the cycle is modified due to toxicity/delay, and repeated every 3 weeks until disease progression/early termination \\[ET\\]\n\nrAd-IFN: Adenovirus-Delivered Interferon Alpha-2b\n\nCelecoxib Oral Product: 400 mg twice daily\n\nGemcitabine: 1250 mg/m2 administered intravenously on Days 1 and 8 of a 21-day cycle and continued every 3 weeks until disease progression/ early termination","id":"EG000","otherNumAffected":27,"otherNumAtRisk":27,"seriousNumAffected":10,"seriousNumAtRisk":27,"title":"Treatment Group"},{"deathsNumAffected":19,"deathsNumAtRisk":26,"description":"Celecoxib (Study Days 1 to 14) + gemcitabine (Study Days 14 and 21 \\[i.e., Days 1 and 8 of the first gemcitabine treatment cycle\\], gemcitabine will be administered on a 21-day cycle, unless the cycle is modified due to toxicity/delay, and repeated every 3 weeks until disease progression/ET.\n\nCelecoxib Oral Product: 400 mg twice daily\n\nGemcitabine: 1250 mg/m2 administered intravenously on Days 1 and 8 of a 21-day cycle and continued every 3 weeks until disease progression/ early termination","id":"EG001","otherNumAffected":22,"otherNumAtRisk":22,"seriousNumAffected":12,"seriousNumAtRisk":22,"title":"Control Group"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":27,"numEvents":27},{"groupId":"EG001","numAffected":8,"numAtRisk":22,"numEvents":20}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":27,"numEvents":7},{"groupId":"EG001","numAffected":6,"numAtRisk":22,"numEvents":12}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":27,"numEvents":27},{"groupId":"EG001","numAffected":4,"numAtRisk":22,"numEvents":5}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":27,"numEvents":8},{"groupId":"EG001","numAffected":5,"numAtRisk":22,"numEvents":9}],"term":"Oedema peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Non-cardiac chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Malaise"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Cather site extravasation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":27,"numEvents":16},{"groupId":"EG001","numAffected":8,"numAtRisk":22,"numEvents":10}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":27,"numEvents":4},{"groupId":"EG001","numAffected":3,"numAtRisk":22,"numEvents":3}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":3,"numAtRisk":22,"numEvents":3}],"term":"Pleural effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Dyspnoea exertional"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Pneumothorax"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":27,"numEvents":34},{"groupId":"EG001","numAffected":9,"numAtRisk":22,"numEvents":18}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":27,"numEvents":10},{"groupId":"EG001","numAffected":6,"numAtRisk":22,"numEvents":17}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":4}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":3}],"term":"Leukopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Thrombocytosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":27,"numEvents":39},{"groupId":"EG001","numAffected":7,"numAtRisk":22,"numEvents":12}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":27,"numEvents":4},{"groupId":"EG001","numAffected":6,"numAtRisk":22,"numEvents":7}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":27,"numEvents":8},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":27,"numEvents":7},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Abdominal distention"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Dyspep[sia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Stomatitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":27,"numEvents":5},{"groupId":"EG001","numAffected":3,"numAtRisk":22,"numEvents":3}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":27,"numEvents":5},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":27,"numEvents":5},{"groupId":"EG001","numAffected":4,"numAtRisk":22,"numEvents":10}],"term":"Neutrophil count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":14},{"groupId":"EG001","numAffected":4,"numAtRisk":22,"numEvents":9}],"term":"White blood cell count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":3,"numAtRisk":22,"numEvents":5}],"term":"Gamma-glutamyltransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Amylase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":4,"numAtRisk":22,"numEvents":4}],"term":"Blood creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":7},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":7}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":4,"numAtRisk":22,"numEvents":4}],"term":"Weight decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":3,"numAtRisk":22,"numEvents":10}],"term":"Blood alkaline phosphatase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":6},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":2}],"term":"Lipase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":7},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Lymphocyte count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Body temperature increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Electrocardiogram QT prolonged"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":27,"numEvents":9},{"groupId":"EG001","numAffected":6,"numAtRisk":22,"numEvents":9}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":27,"numEvents":4},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Hypoalbuminaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Hyponatraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Hyperglycaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":2}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Hypomagnesaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Hypophosphataemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":27,"numEvents":4},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Musculoskeletal chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":27,"numEvents":4},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":3}],"term":"Myalgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":3}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":4},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Muscular weakness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":27,"numEvents":4},{"groupId":"EG001","numAffected":4,"numAtRisk":22,"numEvents":7}],"term":"Rash"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":2}],"term":"Rash maculo-papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Erythema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Hyperhidrosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":27,"numEvents":5},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Lower respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":3}],"term":"Oral candidiasis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":4},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Cystitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Viral upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":6},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":27,"numEvents":5},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":2}],"term":"Lethargy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":3,"numAtRisk":22,"numEvents":3}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":3,"numAtRisk":22,"numEvents":3}],"term":"Depression"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Anxiety"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":27,"numEvents":5},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Procedural pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":27,"numEvents":11},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":9}],"term":"Proteinuria"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Haematuria"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Urinary retention"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":12},{"groupId":"EG001","numAffected":3,"numAtRisk":22,"numEvents":4}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":3}],"term":"Hepatocellular injury"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":4}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Hypoxia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Cardiac failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":22,"numEvents":2}],"term":"Infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Clostridium difficile infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Lower respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Pleural infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Pneumonia viral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":27,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Pleural effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Pulmonary embolism"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Acute respiratory failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Pneumothorax"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Pulmonary opedema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":27,"numEvents":3},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Malaise"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Pericardial effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Colitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Lower gastrointestinal haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Vertigo"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Cytokine release syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":27,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":22,"numEvents":0}],"term":"Spinal cord injury thoracic"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Dehydration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 23.0","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":27,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":22,"numEvents":1}],"term":"Confusional state"}],"timeFrame":"The Safety Analysis Set comprises all patients who received at least 1 dose of study drug (rAd-IFN, celecoxib, or gemcitabine), from study start on 27 August 2019 to Data Cut-off on 07 May 2024, a period of 4 years and 8 months. Safety follow-up for patients in the active treatment group continued for each individual for a period of five years from initial dosing. During this period no further safety events were observed and no updates to the CSR were required. The LPLV was on 16 January 2026."}